Refractory Mycosis Fungoides/Sezary Syndrome

Also known as: Mycosis fungoides/Sezary syndrome refractory / Refractory Mycosis Fungoides and Sezary Syndrome / Cutaneous T-cell lymphoma refractory

DrugDrug NameDrug Description
DB12498MogamulizumabA monoclonal antibody used to treat relapsed or refractory mycosis fungoides or S├ęzary syndrome after attempting one other therapy.
DrugDrug NamePhaseStatusCount
DB16225Magrolimab1 / 2Active Not Recruiting1
DB12498Mogamulizumab1 / 2Active Not Recruiting1
DB00033Interferon gamma-1b2Completed1
DB09037Pembrolizumab2Completed2